Technology
Health
Medical

Sensus

$6.36
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.08 (1.27%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell Sensus and other stocks, options, ETFs, and crypto commission-free!

About SRTS

Sensus Healthcare, Inc. engages in the design, manufacture, and marketing of proprietary medical devices specializing in the treatment of non-melanoma skin cancers and other skin conditions. Its main product is SRT-100, a photon x-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating basal cell and squamous cell skin cancers and other skin conditions such as keloids. Read More The company was founded by Joseph C. Sardano, Richard Golin, Kalman Fishman and Stephen Cohen on May 7, 2010 and is headquartered in Boca Raton, FL.

Employees
48
Headquarters
Boca Raton, Florida
Founded
2010
Market Cap
104.92M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
27.04K
High Today
$6.45
Low Today
$6.28
Open Price
$6.28
Volume
14.94K
52 Week High
$9.23
52 Week Low
$4.75

Collections

Technology
Health
Medical
Healthcare
Advertising and Marketing
Medical Devices
Energy
Business Services

SRTS News

ReutersAug 9

Edited Transcript of SRTS earnings conference call or presentation 8-Aug-19 8:30pm GMT

7

SRTS Earnings

-$0.13
-$0.08
-$0.04
$0.01
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
-$0.05 per share
Actual
$0.01 per share

More SRTS News

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.